Global engagement

Global engagement

Global engagement: Promoting innovative and inclusive approaches to research

An essential part of TDR’s work is to engage with the global health community to promote and facilitate the role of research for development and to advocate for the use of high-quality evidence to inform policy. TDR is at the interface between research and health care delivery and is embedded within the UN family through its cosponsors (UNICEF, UNDP, the World Bank, and WHO). This unique positioning allows TDR to create a bridge from local communities to the World Health Assembly to enable the broadest possible scope of dialogue and debate across the spectrum of health research – from priority setting to evidence-based policy-making at local, national, regional and global levels.

This global engagement includes promoting a broad range of community-based social innovations that are transforming health care delivery, shaping the research agenda, supporting the translation of evidence to policy, and leveraging a global network of more than 7000 scientists and experts who have been associated with TDR.
   

Recent news

29 May 2024
News release

New report highlights the impact of global health R&D for neglected diseases
23 June 2021
News release

A new self-financed Social Innovation in Health Initiative hub in India
21 June 2021
News release

Communicating research findings with a KISS
13 June 2021
News release

Supporting migration health research in the Eastern Mediterranean Region
8 June 2021
News release

Twelve scientists in the WHO European Region awarded TDR grants on implementation and operational research on TB and COVID-19
20 April 2021
News release

Monitoring and evaluating social innovations in health

Publications

WHO preferred product characteristics for herpes simplex virus vaccines

14 May 2019
 | Publication
WHO preferred product characteristics for herpes simplex virus vaccines
Download (2.1 MB)

Overview

Development of one or more herpes simplex virus (HSV) vaccines is an important objective for sexual and reproductive health worldwide. WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vaccines in priority disease areas.

PPCs are intended to encourage innovation and development of vaccines for use in settings most relevant to the global unmet public health need. HSV vaccine PPCs describe global public health goals for HSV vaccines and preferred parameters pertaining to vaccine indications and target populations, safety and efficacy considerations, research and development, and immunization strategies.

WHO Team
Sexual and Reproductive Health and Research
Editors
WHO
Number of pages
32
Reference numbers
ISBN: 978-92-4-151558-0
Copyright
CC BY-NC-SA 3.0 IGO